Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells
Open Access
- 1 January 2016
- journal article
- research article
- Published by Medknow in Research in Pharmaceutical Sciences
- Vol. 11 (6) , 470-475
Abstract
Lovastatin as a member of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors is used as a lipid-lowering agent. It can also inhibit the formation of hydrogen peroxide and superoxide anion and finally leads to decline in oxidative stress processes. Here, we evaluated whether lovastatin can increase DNA damage resistance of HepG2 cells against genotoxicity of the anticancer drug bleomycin (BLM). HepG2 cells were incubated with different concentrations of lovastatin (0.1, 0.5, 1, 5 µM) before exposure to BLM (0.5 µg/mL for one h). The genotoxic dose of BLM and lovastatin was separately determined and comet assay was used to evaluate the genotoxicity. After trapping cells in agarose coated lames, they were lysed and the electrophoresis was done in alkaline pH, then colored and monitored by florescent microscope. The results of this study indicated that lovastatin in doses lower than 5 µM has genoprotective effect and in doses higher than 50 µM is genotoxic. In conclusion, lovastatin is able to protect genotoxic effects of BLM in HepG2 cells. Further studies are needed to elucidate the mechanism(s) involved in this process.Keywords
This publication has 29 references indexed in Scilit:
- Differential Effects of Lovastatin on Cisplatin Responses in Normal Human Mesothelial Cells versus Cancer Cells: Implication for TherapyPLOS ONE, 2012
- Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicityCell Death & Disease, 2011
- Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methodsProceedings of the National Academy of Sciences, 2010
- Effects of Bleomycin for Epidermoid Carcinoma of Head and NeckJapanese Journal of Clinical Oncology, 2010
- Neutral Cysteine Protease Bleomycin Hydrolase Is Essential for the Breakdown of Deiminated Filaggrin into Amino AcidsJournal of Biological Chemistry, 2009
- Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavageNucleic Acids Research, 2008
- Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposideBritish Journal of Pharmacology, 2006
- Modulation of antioxidant enzymes in bleomycin‐treated rats by vitamin c and β‐caroteneNutrition and Cancer, 1997
- The kinetics of DNA damage by bleomycin in mammalian cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Mechanism of bleomycin action: studiesLife Sciences, 1981